Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT

European Journal of Heart Failure
John G F ClelandAndrew L Clark

Abstract

This article provides information and a commentary on trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the annual meeting of the European Society of Cardiology held in Barcelona in 2009. The AAA study does not support the routine use of aspirin for the prevention of vascular events in patients with asymptomatic atherosclerosis. RELY suggests that dabigatran may be more effective than warfarin for the prevention of stroke in patients with atrial fibrillation. Rolofylline was not superior to placebo in improving outcomes in patients with acute heart failure enrolled in the PROTECT study, but dyspnoea was improved. Data from ACTIVE-I suggest that irbesartan does not provide additional therapeutic benefit in patients with atrial fibrillation who are well controlled on current therapy. The European cardiac resynchronization therapy (CRT) survey provides interesting epidemiological data on current CRT device usage. The German pre-SCD II registry identified a low prevalence of patients with a reduced ejection fraction following myocardial infarction. Implantation of CRT-D rather than an implantable cardioverter defibrillator in patients with mild heart failure and QRS >/=130 ms reduced th...Continue Reading

References

Dec 17, 2003·European Journal of Heart Failure·Jacob Eifer MøllerUNKNOWN Bucindolol Evaluation in Acute Myocardial Infarction Trail Group
Dec 14, 2004·The New England Journal of Medicine·Stefan H HohnloserUNKNOWN DINAMIT Investigators
Nov 9, 2005·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Arthur J MossWojciech Zareba
May 10, 2006·Journal of the American College of Cardiology·Ilan GoldenbergUNKNOWN MADIT-II Investigators
Feb 5, 2008·European Journal of Heart Failure·Volker VallonScott Thomson
Nov 29, 2008·Journal of the American College of Cardiology·Cecilia LindeUNKNOWN REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group
Feb 21, 2009·European Journal of Heart Failure·UNKNOWN CRT Survey Scientific Committee
Apr 2, 2009·The New England Journal of Medicine·Stuart J ConnollySalim Yusuf
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Sep 3, 2009·European Heart Journal·Kenneth DicksteinUNKNOWN National Coordinators
Sep 3, 2009·The New England Journal of Medicine·Arthur J MossUNKNOWN MADIT-CRT Trial Investigators
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski

❮ Previous
Next ❯

Citations

Aug 7, 2012·Current Heart Failure Reports·Rasmus Havmöller, Sumeet S Chugh
Feb 25, 2010·Nature Reviews. Cardiology·Alexander Burashnikov, Charles Antzelevitch
Mar 9, 2010·European Heart Journal·Peter S PangMihai Gheorghiade
May 13, 2011·Critical Pathways in Cardiology·David D McManusRamachandran S Vasan
Jul 13, 2013·Wiener klinische Wochenschrift·Hana Matejovska KubesovaJan Matejovsky
Feb 10, 2012·The American Journal of the Medical Sciences·Shilpa KshatriyaDaniel Villarreal
Jul 9, 2010·The American Journal of the Medical Sciences·Shilpa KshatriyaDaniel Villarreal
Sep 20, 2011·Heart Failure Clinics·Shelby D ReedKevin A Schulman
Feb 1, 2011·Revista española de cardiología·Luis AlmenarEnrique Pérez de la Sota
Sep 20, 2015·Journal of Cardiothoracic and Vascular Anesthesia·Himani V Bhatt, Gregory W Fischer
Sep 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Afschin GandjourCharles Christian Adarkwah
Jul 4, 2017·Echocardiography·Reyan GhanyLeonardo Tamariz
Mar 18, 2010·Circulation. Heart Failure·G Michael FelkerUNKNOWN International AHFS Working Group
Oct 13, 2010·Circulation·Neal L WeintraubUNKNOWN American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and R
Dec 18, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·James C CoonsSrinivas Murali
Apr 28, 2010·Nature Reviews. Cardiology·Ashok J ShahMichel Haïssaguerre
Sep 22, 2011·Expert Review of Cardiovascular Therapy·Michael J BoniosJohn N Nanas
Feb 26, 2016·Journal of Cardiovascular Pharmacology·Benjamin W Van TassellAntonio Abbate

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.